Sunday, July 05, 2026 10:01 PM ET
4 days ago
Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs4 days ago
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes5 days ago
Cramer says this aerospace stock is significantly undervalued, sees 35% upside5 days ago
Medicare will start covering obesity drugs. Here's what patients should know5 days ago
French biotech stock soars 40% after new data on experimental medicine5 days ago
FDA names first companies chosen for faster review of new manufacturing plants5 days ago
Medicare is about to cover obesity drugs — but many seniors may not know it yet7 days ago
Estrogen patches are hard to find, and it may not be resolved any time soon9 days ago
Chan Zuckerberg Initiative's Biohub to open new rare disease funding round10 days ago
This life sciences stock has a secret weapon, and AI will only make it more valuable11 days ago
Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy11 days ago
UPS to invest $48 million in cold facilities amid GLP-1 boom12 days ago
SNAP restrictions could change what shoppers buy — and food giants are watching15 days ago
U.S. opens tariff probe targeting Germany's drug pricing policies16 days ago
What this biotech's volatile stock price tells you about the weight loss market right now16 days ago
UniQure to seek FDA approval for Huntington's disease gene therapy in reversal16 days ago
Biotech IPO revival faces competition from cash-rich big pharma buyers19 days ago
Centene to offer buyouts to some employees as health insurer cuts costs20 days ago
Drugmakers race to find a place in the next wave of obesity drugs22 days ago
CVS Health executives on reducing healthcare's biggest pain points22 days ago
Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'24 days ago
How screwworm in U.S. cattle herds could re-inflate record beef prices25 days ago
The space race is coming for pharma: Why drug development is heading to orbit25 days ago
Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion26 days ago
Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why27 days ago
GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors27 days ago
Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says27 days ago
Weight loss drug maker sinks 23% after new safety data spooks investors27 days ago
U.S. confirms second Texas screwworm case, Canada restricts livestock imports29 days ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success1 month ago
Warren Buffett disciple Guy Spier's rare cancer changed how he values everything1 month ago